Verified· 3 sources

Granite Bio AG

Summary

About the company

Granite Bio AG is a biotechnology company developing first-in-class therapeutic antibodies for inflammatory, autoimmune and fibrotic diseases. Its pipeline includes GRT-001, an antibody that depletes pro-inflammatory monocytes and is in Phase 1b for inflammatory bowel disease, and GRT-002, an interleukin-3–blocking antibody in preclinical development expected to enter clinical trials in 2026.

AI-generated

Offering

Products & services

Industry:Pharmaceutical Industry

✓ Offered

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

Granite Bio AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

Granite Bio AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

Media

No knowledge articles yet

Granite Bio AG in comparison

Industry comparisons are coming soon

Similar companies